Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OmegaChild - Omega-3 Supplementation to Children Now in Full Remission From a Previous Cancer; an Early Phase Dose-finding Study.

NCT02134600 is registered in ClinicalTrials.gov with Per Kogner as lead sponsor.

NCT NCT02134600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OmegaChild - Omega-3 Supplementation to Children Now in Full Remission From a Previous Cancer; an Early Phase Dose-finding Study.
Lead sponsor
Per Kogner
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2014
Completion date
September 2, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer